Benzinga’s Top Pre- Market Gainers (LIMS, SGEN, CLNE, ARRY, JASO, JAZZ, SPWRA)

Starlims Technologies Limited (NASDAQ: LIMS)(FREE stock trend analysis) is trading at $13.73, surged by 44% in the pre-market session. Yesterday, Abbott Laboratories (NYSE: ABT)(FREE stock trend analysis) reported that it has reached an agreement to acquire Starlims Technologies for $123 million in cash, or $14 a share. The 52-week trading range for LIMS is $3.21 - $11.00. In the last trading session, Starlims Technologies closed at $9.50.

Seattle Genetics, Inc. (NASDAQ: SGEN)(FREE stock trend analysis) has gained 6.26% to $9.50 after Seattle Genetics and Millennium: The Takeda Oncology Company announced that they have entered into an agreement to globally develop and commercialize Brentuximab Vedotin. Seattle Genetics closed at $8.94 in the last trading session.

Clean Energy Fuels Corp. (NASDAQ: CLNE)(FREE stock trend analysis) has climbed up 2.65% to $13.95 in the pre-market session. The 52-week trading range for CLNE is $4.57 - $15.18. So far in the current year, Clean Energy Fuels gained over 120%.

Array BioPharma Inc. (NASDAQ: ARRY)(FREE stock trend analysis) has jumped 28% to $2.88. Yesterday, Array BioPharma, Inc. along with Amgen, Inc. (NASDAQ: AMGN)(FREE stock trend analysis) announced that they have entered into an agreement for Type 2 diabetes. ARRY closed at $2.25 yesterday. The 52-week trading range for JASO is $1.68 - $4.68.

JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO)(FREE stock trend analysis) has moved up 5.28% to $5.58. Yesterday, JA Solar Holdings reported that its Board of Directors has approved a share repurchase program. The 52-week trading range for JASO is $1.77 - $6.29.

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)(FREE stock trend analysis) has surged 3.30% to $8.83 after Jazz Pharmaceuticals announced it has submitted a New Drug Application to the U.S. Food and Drug Administration for the treatment of fibromyalgia. In the last trading session, JAZZ closed at $8.49. So far in the current year, JAZZ gained over 335%.

SunPower Corporation (NASDAQ: SPWRA)(FREE stock trend analysis) has climbed 3% to $23.90. Yesterday, SunPower Corporation announced that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of a class who purchased the securities of SunPower between April 17, 2008 and November 16, 2009. So far in 2009, SPWRA declined by over 35%.